发明名称 PREPARATION OF Ó-ARYLALKANOIC ACIDS
摘要 Pharmaceutically useful optically active .alpha.-arylalkanoic acids or esters, ortho esters, or amides thereof are stereoselectively prepared by contacting an aryl magnesium Grignard reagent with an optically active .alpha.-substituted acyl halide to form the optically active aryl .alpha.-substituted alkyl ketone, which is ketalized and rearranged to the desired optically active .alpha.-arylalkanoic acid or the corresponding ester, ortho ester or amide. In an alternate embodiment, the aryl .alpha.-substituted alkyl ketone is reduced to the corresponding alkanol, which is rearranged to the .alpha.-arylalkanal. The alkanal so produced is converted to the desired optically active .alpha.-arylalkanoic acid by conventional methods.
申请公布号 CA1338433(C) 申请公布日期 1996.07.02
申请号 CA19920616341 申请日期 1992.05.13
申请人 SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED 发明人 SCHLOEMER, GEORGE C.
分类号 C07C41/60;C07B61/00;C07C;C07C41/00;C07C41/50;C07C43/295;C07C43/307;C07C43/313;C07C43/315;C07C43/32;C07C45/00;C07C45/45;C07C45/54;C07C45/68;C07C47/277;C07C49/76;C07C49/84;C07C51/00;C07C57/30;C07C57/40;C07C57/46;C07C59/64;C07C67/00;C07C67/343;C07C67/40;C07C67/42;C07C67/44;C07C67/475;C07C69/007;C07C69/025;C07C69/157;C07C69/527;C07C69/616;C07C69/712;C07C69/734;C07C69/767;C07C69/78;C07C231/00;C07C231/02;C07C233/11;C07C301/00;C07C303/30;C07C309/63;C07C309/66;C07C309/73;C07D309/22;C07D317/02;C07D317/06;C07D317/14;C07D317/18;C07D317/22;C07D317/24;C07D319/06;C07F3/02;C07F3/06;C07F7/08;C07F7/18;C07F13/00;(IPC1-7):C07C43/315 主分类号 C07C41/60
代理机构 代理人
主权项
地址